AKT1 and metabolic syndrome: In cardiac tissue, such hyperactivation of insulin/Akt signaling pathway has been described in other pathophysiological contexts, such as early stages of heart failure (i.e., pressure overload model) (Shimizu et al., 2010) or metabolic syndrome (i.e., ob/ob mice) (Cook et al., 2010).